GSK (GSK) and Empirico announced that they have entered into a worldwide exclusive license agreement for EMP-012, a selective first- and ...

During a recent interview on CNN, Ted Cruz described what he considers an under-reported threat to national security: Electromagnetic pulse, or EMP, attacks. He explained that this danger involves “a ...

GSK’s antibody-drug conjugate strategy may be making more headlines recently, but the British pharma hasn’t forgotten about ...

I became involved in the issue of EMP nearly 15 years ago, when I undertook the writing of a novel about the potential impact and after-effects of an EMP strike on the United States. As a trained ...